We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Avantor, Inc. (AVTR - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Avantor, Inc. is one of 918 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Avantor, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AVTR's full-year earnings has moved 2.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, AVTR has returned 32.6% so far this year. At the same time, Medical stocks have gained an average of 5.4%. This shows that Avantor, Inc. is outperforming its peers so far this year.
Another stock in the Medical sector, BrightSpring Health Services, Inc. (BTSG - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 64%.
The consensus estimate for BrightSpring Health Services, Inc.'s current year EPS has increased 7.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Breaking things down more, Avantor, Inc. is a member of the Medical Services industry, which includes 72 individual companies and currently sits at #86 in the Zacks Industry Rank. On average, this group has gained an average of 3.9% so far this year, meaning that AVTR is performing better in terms of year-to-date returns. BrightSpring Health Services, Inc. is also part of the same industry.
Investors interested in the Medical sector may want to keep a close eye on Avantor, Inc. and BrightSpring Health Services, Inc. as they attempt to continue their solid performance.
View the Zacks #1 Rank List
Image: Bigstock
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Avantor, Inc. (AVTR - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Avantor, Inc. is one of 918 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Avantor, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AVTR's full-year earnings has moved 2.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, AVTR has returned 32.6% so far this year. At the same time, Medical stocks have gained an average of 5.4%. This shows that Avantor, Inc. is outperforming its peers so far this year.
Another stock in the Medical sector, BrightSpring Health Services, Inc. (BTSG - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 64%.
The consensus estimate for BrightSpring Health Services, Inc.'s current year EPS has increased 7.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Breaking things down more, Avantor, Inc. is a member of the Medical Services industry, which includes 72 individual companies and currently sits at #86 in the Zacks Industry Rank. On average, this group has gained an average of 3.9% so far this year, meaning that AVTR is performing better in terms of year-to-date returns. BrightSpring Health Services, Inc. is also part of the same industry.
Investors interested in the Medical sector may want to keep a close eye on Avantor, Inc. and BrightSpring Health Services, Inc. as they attempt to continue their solid performance.